Natural cell-mediated cytotoxicity among A-bomb survivors residing in the United States
- 1. California Univ., Los Angeles (USA). School of Medicine
- 2. West Los Angeles V.A. Medical Center, Wadsworth Div. (USA)
- 3. California Univ., Los Angeles (USA)
Description
Natural cell-mediated cytotoxicity (NCMC) by lymphocytes from Japanese atomic bomb survivors now living in the United States was measured. Seventy-one individuals were exposed to an estimated '0.00' Gy ('0 rads') (S0 group) and 58 to greater than '0.00 Gy' (Ssub(+) group) at the time of the bomb. Of this 58,51 (88 per cent) received less than 0.50 Gy and 30 (52 per cent) received less than 0.10 Gy. NCMC was measured against 51Cr-labelled K562 target cells. Activity by lymphocytes from Ssub(+) group donors was significantly greater than that for the S0 group (p=0.028 by the stratified Wilcoxon rank-sum test). This difference between the Ssub(+) and S0 populations was detected 35 years after exposure to the bomb. It is therefore feasible and important to examine appropriate biologic parameters to elucidate the effects of low doses of radiation in humans. (author)
Additional details
Publishing Information
- Journal Title
- Int. J. Radiat. Biol. Relat. Stud. Phys., Chem. Med.
- Journal Volume
- 44
- Journal Issue
- 2
- Series
- Int. J. Radiat. Biol. Relat. Stud. Phys., Chem. Med.
- Journal Page Range
- 213-218
- ISSN
- 0020-7616
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- United Kingdom
- INIS RN
- 15005833
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- A-BOMB SURVIVORS; BIOASSAY; DELAYED RADIATION EFFECTS; LOW DOSE IRRADIATION; LYMPHOCYTES; RADIATION DOSES
- Descriptors DEC
- ANIMAL CELLS; BIOLOGICAL EFFECTS; BIOLOGICAL MATERIALS; BIOLOGICAL RADIATION EFFECTS; BLOOD; BLOOD CELLS; BODY FLUIDS; CONNECTIVE TISSUE CELLS; IRRADIATION; LEUKOCYTES; MATERIALS; PERFORMANCE TESTING; RADIATION EFFECTS; SOMATIC CELLS; TESTING